ALDX Investors Face May 29 Deadline in Securities Fraud Class Action Over Failed Drug Trial
$ALDX shareholders face May 29 deadline to join securities fraud class action alleging false reproxalap trial disclosures. Eligible investors with documented losses can pursue recovery through lawsuit.
ALDXsecurities fraudclass action lawsuit